Filing Details
- Accession Number:
- 0001140361-16-088699
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-12-02 19:11:27
- Reporting Period:
- 2016-12-01
- Filing Date:
- 2016-12-02
- Accepted Time:
- 2016-12-02 19:11:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1527599 | Mirna Therapeutics Inc. | MIRN | Pharmaceutical Preparations (2834) | 261824804 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1652055 | Jon Irvin | C/O Mirna Therapeutics, Inc. 3711 South Mopac Expressway, Ste 100 Austin TX 78746 | Vice President, Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-12-01 | 280 | $1.43 | 7,625 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 29, 2016.